Literature DB >> 18308783

Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports.

O Oner1, P Oner.   

Abstract

We present the treatment of three very young preschool patients (four- to five-year old) with obsessive-compulsive disorder (OCD). Two of the patients had severe ego-dystonic obsessions with sexual, aggressive, religious themes and forbidden thoughts, while the other one had contamination obsession and cleaning compulsions. Physical and neurological examination and laboratory work-up did not reveal any abnormalities. The symptoms resolved after sertaline monotherapy up to 50 mg/day and sertraline plus risperidone 0.5 mg/day (two cases) treatment. There is very limited data on the treatment of such young pediatric population of patients with OCD and, especially, the safety of using such psychotropic drugs in this special population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308783     DOI: 10.1177/0269881107083362

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  4 in total

1.  Preschool children with obsessive-compulsive disorder and fluoxetine treatment.

Authors:  Eyup Sabri Ercan; Rasiha Kandulu; Ulku Akyol Ardic
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-01-22       Impact factor: 4.785

Review 2.  Internalizing disorders in early childhood: a review of depressive and anxiety disorders.

Authors:  Mini Tandon; Emma Cardeli; Joan Luby
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-07

Review 3.  Current state of evidence for medication treatment of preschool internalizing disorders.

Authors:  Justin A Barterian; Erin Rappuhn; Erin L Seif; Gabriel Watson; Hannah Ham; John S Carlson
Journal:  ScientificWorldJournal       Date:  2014-01-27

4.  Escitalopram in Preschool-Age Children Diagnosed with Obsessive ‎Compulsive Disorder: A Case Report ‎.

Authors:  Kemal Utku Yazici; Ipek Percinel
Journal:  Iran J Psychiatry       Date:  2016-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.